Amicus Therapeutics CEO Bradley Campbell sells $85,959 in stock

Nov 4, 2024 · According to a recent SEC filing, Campbell sold 7,500 shares of Amicus Therapeutics ' common stock, with the sale price averaging $11.4613 per share, totaling …

CouponFollow Extension

$85959
OFF

Amicus Therapeutics CEO Bradley Campbell Sells $85,959 In Stock

3 weeks from now

Nov 4, 2024 · According to a recent SEC filing, Campbell sold 7,500 shares of Amicus Therapeutics ' common stock, with the sale price averaging $11.4613 per share, totaling …

investing.com

$85959
OFF

Amicus Therapeutics CEO Bradley Campbell Sells $85,959 In Stock

3 weeks from now

Amicus Therapeutics CEO Bradley Campbell sells $85,959 in stock

investing.com

$85959
OFF

Amicus Therapeutics CEO Bradley Campbell Sells $85,959 In Stock

3 weeks from now

On November 1, Bradley L. Campbell, President and CEO of Amicus (NASDAQ: FOLD) Therapeutics (NASDAQ:FOLD), executed a notable stock transaction.According to a recent …

investing.com

$11.46
OFF

Amicus Therapeutics CEO Sells 7,500 Shares - TradingView

3 weeks from now

Nov 4, 2024 · Bradley L. Campbell, President and CEO of Amicus Therapeutics, sold 7,500 shares of common stock on November 1, 2024, at a weighted average price of $11.4613, …

tradingview.com

$75124
OFF

Amicus Therapeutics CEO Campbell Bradley Sells $75,124 In Stock

3 weeks from now

Dec 3, 2024 · In a recent transaction, Campbell Bradley L, the President and CEO of Amicus Therapeutics , Inc. (NASDAQ: FOLD), a $2.92 billion biotechnology company with impressive …

investing.com

$98800
OFF

Amicus Therapeutics CEO Campbell Sells $98,800 In Stock

3 weeks from now

Nov 7, 2024 · Campbell Bradley L, the President and CEO of Amicus Therapeutics , Inc. (NASDAQ: FOLD), recently sold shares of the company as reported in a recent SEC filing. On …

investing.com

$10.64
OFF

Bradley Campbell Net Worth, Biography, And Insider Trading

3 weeks from now

The estimated net worth of Bradley L. Campbell is at least $10.64 million as of August 1st, 2023. Mr. Campbell owns 798,554 shares of Amicus Therapeutics stock worth more than …

insidertrades.com

$10.01
OFF

Amicus Therapeutics CEO Sells 7,500 Shares - TradingView

3 weeks from now

Dec 3, 2024 · Bradley L. Campbell, President and CEO of Amicus Therapeutics, sold 7,500 shares of common stock on December 2, 2024, at a weighted average price of $10.0166 per …

tradingview.com

$1
OFF

Janux Therapeutics CEO Sells $1.4M In Common Stock

3 weeks from now

4 days ago · In a regulatory filing on Friday, Janux Therapeutics (JANX) disclosed that its CEO David Campbell sold 25K shares of common stock on December 24th in a total transaction …

nasdaq.com

FAQs about Amicus Therapeutics CEO Bradley Campbell sells $85,959 in stock Coupon?

Did Bradley Campbell buy Amicus Therapeutics Inc?

Over the past year, Bradley Campbell has sold a total of 182,078 shares and has not made any purchases. This recent sale of 11,700 shares is part of a larger trend of insider selling at Amicus Therapeutics Inc. Over the past year, there have been 45 insider sells and no insider buys. ...

What is the gf value of Amicus Therapeutics Inc?

The GF Value of Amicus Therapeutics Inc is $13.19, and the price-to-GF-Value ratio is 0.83. On November 1, 2023, Bradley Campbell, President and CEO of Amicus Therapeutics Inc (NASDAQ:FOLD), sold 11,700 shares of the company. ...

Is Amicus Therapeutics Inc stock undervalued?

On the day of the insider's recent sale, shares of Amicus Therapeutics Inc were trading at $10.97, giving the company a market cap of $3.37 billion. According to the GuruFocus Value, which is an intrinsic value estimate developed by GuruFocus, the stock is modestly undervalued. ...

Do insiders sell or buy Amicus Therapeutics Inc?

Over the past year, there have been 45 insider sells and no insider buys. The insider's selling activities often provide valuable insights into the company's performance and future prospects. In the case of Amicus Therapeutics Inc, the consistent selling by the insider could be interpreted in various ways. ...